English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
愛格法醫療榮獲2026年KLAS(R)評鑑美國三大企業影像領域最佳供應商殊榮
Feb 05, 2026 05:00 HKT
上实集团携手Azzurra Capital合作落地 共启亚洲绿色科技投资
Feb 03, 2026 08:00 HKT
上實集團攜手Azzurra Capital合作落地 共啟亞洲綠色科技投資
Feb 03, 2026 08:00 HKT
Formerra and Evonik Expand Distribution Partnership for Healthcare Grades
Feb 02, 2026 22:00 HKT
福美拉与赢创扩大医疗级产品分销合作
Feb 02, 2026 22:00 HKT
福美達與愛信諾擴大醫療級產品分銷合作
Feb 02, 2026 22:00 HKT
Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics
Feb 02, 2026 20:00 HKT
君圣泰医药任命Filip Surmont博士为首席医学官 强化心肾代谢系统疾病(CKM)布局
Feb 02, 2026 18:39 HKT
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Jan 30, 2026 21:30 HKT
康哲藥業(867.HK/8A8.SG):磷酸蘆可替尼乳膏獲批 為中國批准的首款且唯一白癜風靶向藥
Jan 30, 2026 15:22 HKT
康哲药业(867.HK/8A8.SG):磷酸芦可替尼乳膏获批 为中国批准的首款且唯一白癜风靶向药
Jan 30, 2026 15:13 HKT
腾讯等豪华股东阵容加持业绩增长亮眼 卓正医疗招股进行中
Jan 30, 2026 11:27 HKT
騰訊等豪華股東陣容加持業績增長亮眼 卓正醫療招股進行中
Jan 30, 2026 11:14 HKT
Formerra to Supply Foster Medical Compounds in Europe
Jan 29, 2026 22:00 HKT
Formerra将向欧洲供应福斯特医药化合物
Jan 29, 2026 22:00 HKT
Formerra將供應福斯特醫療化合物至歐洲市場
Jan 29, 2026 22:00 HKT
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
Jan 29, 2026 20:57 HKT
Geon Performance Solutions Updates Brand Identity to Reflect Expanded Capabilities in Polymer Industry
Jan 23, 2026 07:00 HKT
Geon高性能解决方案更新品牌形象,彰显聚合物行业拓展实力
Jan 23, 2026 07:00 HKT
Geon Performance Solutions更新品牌識別,彰顯聚合物產業擴展實力
Jan 23, 2026 07:00 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: